Try our Advanced Search for more refined results

Perrigo Company v. United States of America

  1. May 01, 2020

    COVID-19 IP Catch-Up: Looming Trials, Jeff Dunham's Dummy

    The copyright and patent offices have pushed back certain deadlines as the COVID-19 pandemic continues, while at least one intellectual property bench trial is about to proceed over video. Here, Law360 pulls together all the updates you might have missed, including victories for 3M in its trademark campaign and a new suit by comedian Jeff Dunham seeking to protect his image.

  2. April 28, 2020

    Perrigo's $163.5M Tax Trial Dates Canceled Amid Virus

    A Michigan federal judge Tuesday canceled trial dates scheduled in Perrigo's $163.5 million tax refund suit because of health concerns surrounding the coronavirus and said the trial could not proceed by video because of the complexities posed by the case.

  3. February 14, 2020

    Israeli Drugmaker Can Intervene In $163M Perrigo-US Row

    A Michigan federal judge on Friday partially granted an Israeli drugmaker permission to intervene in Perrigo's suit to recoup a $163.5 million tax refund, but only to the extent necessary to safeguard its trade secrets.

  4. January 28, 2020

    Drugmaker Asks For Info Protection In $163M Perrigo-US Row

    An Israeli drugmaker alleged by the U.S. to have made a distribution agreement with Perrigo that lacked economic substance has asked a Michigan federal court to safeguard its trade secrets while Perrigo pursues a $163.4 million tax refund in court.

  5. October 11, 2019

    Court Allows $163M Perrigo-US Tax Dispute To Continue

    A Michigan federal court on Friday denied both the U.S. and Perrigo summary judgment in their $163 million international tax dispute over a Perrigo offshore subsidiary's heartburn drug contract.

  6. June 06, 2019

    Perrigo Set Up Israeli Co. To Skip Tax, US Says In $163M Row

    Perrigo created an Israeli subsidiary in 2006 as an "empty box," and the assignment of a heartburn drug contract to the subsidiary should be disregarded in a $163 million tax dispute, the U.S. has told a Michigan federal court.

  7. May 16, 2019

    Perrigo Says IRS Can't Undo Tax Structure Approval In $163M Row

    Generic drug manufacturer Perrigo told a Michigan federal court that the Internal Revenue Service shouldn't be able to reverse previous approval of the company's international tax structure in its $163.4 million international tax dispute.

  8. April 16, 2019

    No Settlement In Sight In Perrigo's $163M Tax Row With U.S.

    The U.S. government and Irish-registered generic pharmaceutical maker Perrigo Co. have failed to resolve a $163.4 million tax dispute during a settlement conference, according to minutes of the proceeding in a Michigan federal court.

  9. January 22, 2019

    Judge Nixes Perrigo's Bid For IRS Report In $163M Tax Row

    A Michigan federal judge has denied pharmaceutical company Perrigo Co.'s efforts to force the U.S. to produce an Internal Revenue Service economist's report in a $163.4 million tax dispute.

  10. December 17, 2018

    Perrigo Wants IRS Economist's Audit Report In $163.5M Row

    Generic pharmaceutical giant Perrigo Co. has demanded in a Michigan federal court that the U.S. government turn over an economist's report produced during an Internal Revenue Service audit that led to a $163.5 million tax-refund dispute.